Name

MCF

Alternate names

None

Primary Site

None

Histology

None

Radiation

None

Remarks

None

Drugs for MCF

Name

Alternate Names

Ametycine
Mito-Medac
Mitocin
Mitocin-C
MitoExtra
Mitomycin-C
Mitomycin-X
Mutamycin
Mutamycine

Abbreviations

MITC
Mito
MITO-C
MMC
MTC

Category

Chemotherapy

Subcategory

Alkylating agent

NSC Number

26980
026980

Primary Site

Breast
Cervical cancer
Gastric cancer
Head and Neck (in combination with radiation therapy)
Non-small cell lung cancer (NSCLC)
Pancreatic cancer
Superficial bladder cancer

Histology

None

Remarks

FDA approved for treatmen of many cancers.

Coding

This drug should be coded

Name

Alternate Names

5-Fluorouracil
5-Fluracil
Adrucil
Efudex
Fluoroplex
Fluracil
Fluril
Oracil
Ro 2-9757
WR-69596

Abbreviations

5-FU
5FU
FU

Category

Chemotherapy

Subcategory

Antimetabolite

NSC Number

019893
19893

Primary Site

Breast- adjuvant setting and advanced disease
colorectal- adjuvant setting and advanced disease
GI malignancies: anal, esophageal, gastric and pancreatic
Head and Neck cancer
Hepatoma
Ovarian cancer
Skin-Basal cell carcinoma (topical application)

Histology

None

Remarks

Fluorinated pyrimidine; antimetabolite. FDA approved uses on basal cell carcinoma, breast cancer, colorectal cancer, gastric cancer, and pancreatic cancer.

Note: Efudex cream be prescribed to treat AIN III. Code this as chemotherapy.

Coding

This drug should be coded

Name

Alternate Names

Cis-Platin
Cis-Platinum II#
Cisplatino (Spanish)
Cisplatinum
Cisplatyl
Neoplatin
Peyrone's chloride
Platinex
Platinol
Platinol-AQ
Platinol-AQ VHA Plus
Platinum

Abbreviations

CACP
CDDP
Cis-DDP
CPD
CPDC
CPDD
CPPD
DDP

Category

Chemotherapy

Subcategory

Alkylating agent
Platinum analog

NSC Number

119875

Primary Site

Bladder
ovarian
testicular cancer

Histology

None

Remarks

An alkylating antineoplastic agent. FDA approved uses on bladder, ovarian and testicular cancer; miscellaneous agent.

Coding

This drug should be coded
Glossary